Krebs Biochemicals & Industries Ltd (KREBSBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 142337,
    "name": "Krebs Biochem",
    "stock_name": "Krebs Biochem",
    "full_name": "Krebs Biochemicals & Industries Ltd",
    "name_url": "stocks-analysis/krebs-biochem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "56.00",
    "chg": -0.25,
    "chgp": "-0.44%",
    "dir": -1,
    "prev_price": "56.25",
    "mcapval": "120.74 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524518,
    "symbol": "KREBSBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE268B01013",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "314 ",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/krebs-biochem-142337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Krebs Biochemicals & Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-krebs-biochemicals-industries-ltd-latest-results-good-or-bad-3829057",
        "imagepath": "",
        "date": "2026-02-09 19:16:06",
        "description": "Krebs Biochemicals & Industries Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported net sales of ₹7.27 crores, which reflects a significant sequential improvement of 74.34% from the previous quarter, yet this figure is still substantially lower than the ₹11.47 crores recorded in the same quarter of the previous year, indicating a year-on-year decline of 36.62%. This trend of revenue contraction is concerning, especially as the cumulative revenue for the first nine months of FY26 shows a severe contraction of 52.98% compared to the same period last year.\n\nOn the profitability front, Krebs Biochemicals achieved a positive operating margin of 3.99%, a notable turnaround from the previous quarter's negative margin of -66.91%. However, the company still reported a net loss of ₹3.13 crores, which, while a reduction from the prior quarter's loss, remains a significant concern..."
      },
      {
        "title": "Krebs Biochemicals Q3 FY26: Mounting Losses Deepen Crisis as Revenue Collapses 67% YoY",
        "link": "https://www.marketsmojo.com/news/result-analysis/krebs-biochemicals-q3-fy26-mounting-losses-deepen-crisis-as-revenue-collapses-67-yoy-3828960",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrebsBiochemica_quaterlyResult_3828960.png",
        "date": "2026-02-09 16:30:54",
        "description": "Krebs Biochemicals & Industries Ltd. reported a catastrophic third quarter for FY2026, with net losses widening to ₹3.13 crores despite a sequential improvement from the disastrous ₹6.14 crore loss in Q2 FY26. The Visakhapatnam-based active pharmaceutical ingredient (API) manufacturer, which operates one of the world's few fermentation-based production facilities, continues to grapple with severe operational challenges as revenue plummeted 36.62% year-on-year to ₹7.27 crores in Q3 FY26. The stock has reflected this deteriorating fundamental picture, collapsing 45.96% over the past year and trading at ₹55.62 as of February 9, 2026—down 51.17% from its 52-week high of ₹113.90."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-3827248",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrebsBiochemica_mojoScore_3827248.png",
        "date": "2026-02-08 10:10:17",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 08 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-52-week-low-amidst-continued-downtrend-3824305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KrebsBiochemica_priceRelatedfactors_3824305.png",
        "date": "2026-02-06 11:12:07",
        "description": "Krebs Biochemicals & Industries Ltd has touched a new 52-week low of Rs.51 today, marking a significant decline in its stock price amid persistent downward momentum. This latest low reflects ongoing challenges faced by the company within the Pharmaceuticals & Biotechnology sector, with the stock underperforming both its sector peers and broader market indices over the past year."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-3807309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_mojoScore_3807309.png",
        "date": "2026-01-28 10:10:35",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-falls-to-52-week-low-amidst-continued-downtrend-3805909",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_priceRelatedfactors_3805909.png",
        "date": "2026-01-27 11:02:59",
        "description": "Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid a challenging market environment and subdued company performance. The stock's latest decline to this significant price level underscores persistent headwinds within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-52-week-low-amidst-continued-downtrend-3796723",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_priceRelatedfactors_3796723.png",
        "date": "2026-01-20 15:10:34",
        "description": "Krebs Biochemicals & Industries Ltd has touched a new 52-week low of Rs.60.17 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance issues."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-52-week-low-amidst-continued-downtrend-3791205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_priceRelatedfactors_3791205.png",
        "date": "2026-01-12 13:43:05",
        "description": "Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid subdued financial performance and sector underperformance. The stock’s latest decline to this significant price level underscores persistent challenges faced by the company in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-3781580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_mojoScore_3781580.png",
        "date": "2026-01-05 10:11:38",
        "description": "Krebs Biochemicals & Industries Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 122,
    "sid": "142337",
    "stock_news_url": "https://www.marketsmojo.com/news/krebs-biochemicals-industries-142337"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Feb-2026",
      "details": "The Company has enclosing copy of newspaper advertisement of financial results for the quarter ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Results Quarter Ended 31.12.2025",
      "datetime": "09-Feb-2026",
      "details": "Result for the quarter ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "09-Feb-2026",
      "details": "Outcome of Board Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Krebs Biochemicals & Industries Ltd has announced <strong>21:100</strong> rights issue, ex-date: 31 Jan 19",
          "dt": "2019-01-31",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Are Krebs Biochemicals & Industries Ltd latest results good or bad?

2026-02-09 19:16:06

Krebs Biochemicals & Industries Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported net sales of ₹7.27 crores, which reflects a significant sequential improvement of 74.34% from the previous quarter, yet this figure is still substantially lower than the ₹11.47 crores recorded in the same quarter of the previous year, indicating a year-on-year decline of 36.62%. This trend of revenue contraction is concerning, especially as the cumulative revenue for the first nine months of FY26 shows a severe contraction of 52.98% compared to the same period last year. On the profitability front, Krebs Biochemicals achieved a positive operating margin of 3.99%, a notable turnaround from the previous quarter's negative margin of -66.91%. However, the company still reported a net loss of ₹3.13 crores, which, while a reduction from the prior quarter's loss, remains a significant concern...

Read full news article

Krebs Biochemicals Q3 FY26: Mounting Losses Deepen Crisis as Revenue Collapses 67% YoY

2026-02-09 16:30:54

Krebs Biochemicals & Industries Ltd. reported a catastrophic third quarter for FY2026, with net losses widening to ₹3.13 crores despite a sequential improvement from the disastrous ₹6.14 crore loss in Q2 FY26. The Visakhapatnam-based active pharmaceutical ingredient (API) manufacturer, which operates one of the world's few fermentation-based production facilities, continues to grapple with severe operational challenges as revenue plummeted 36.62% year-on-year to ₹7.27 crores in Q3 FY26. The stock has reflected this deteriorating fundamental picture, collapsing 45.96% over the past year and trading at ₹55.62 as of February 9, 2026—down 51.17% from its 52-week high of ₹113.90.

Read full news article

Krebs Biochemicals & Industries Ltd is Rated Strong Sell

2026-02-08 10:10:17

Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 08 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-02-06 11:12:07

Krebs Biochemicals & Industries Ltd has touched a new 52-week low of Rs.51 today, marking a significant decline in its stock price amid persistent downward momentum. This latest low reflects ongoing challenges faced by the company within the Pharmaceuticals & Biotechnology sector, with the stock underperforming both its sector peers and broader market indices over the past year.

Read full news article

Krebs Biochemicals & Industries Ltd is Rated Strong Sell

2026-01-28 10:10:35

Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

Read full news article

Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-01-27 11:02:59

Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid a challenging market environment and subdued company performance. The stock's latest decline to this significant price level underscores persistent headwinds within the Pharmaceuticals & Biotechnology sector.

Read full news article

Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-01-20 15:10:34

Krebs Biochemicals & Industries Ltd has touched a new 52-week low of Rs.60.17 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance issues.

Read full news article

Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-01-12 13:43:05

Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid subdued financial performance and sector underperformance. The stock’s latest decline to this significant price level underscores persistent challenges faced by the company in the Pharmaceuticals & Biotechnology sector.

Read full news article

Krebs Biochemicals & Industries Ltd is Rated Strong Sell

2026-01-05 10:11:38

Krebs Biochemicals & Industries Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News